title: Paediatric kidney transplantation.
abstract: Renal transplantation is the optimal form of renal replacement therapy leading to substantial improvement in the quality of life. It has rapidly become the standard treatment for end-stage renal disease in children. However, despite impressive short-term results significant long-term problems remain unsolved. Because of the lack of effective treatment for chronic rejection and common recipient noncompliance, allograft half-life has not improved significantly during the last decade. A paediatric recipient is likely to need several retransplantations in adulthood. Moreover, the immunosuppressive drugs used today have potentially serious side-effects including nephrotoxicity and de novo malignancy. These are especially relevant for paediatric recipients who will continue to receive therapy for several decades. Most therapeutic protocols used for children are derived from those used for adults. However, the metabolic differences between an adult and a growing and developing paediatric transplant recipient are not always adequately appreciated before these new therapies are initiated. In the near future, we are likely to see new and more efficient drugs become available. It is important that we try to understand their properties in children and use them and our current arsenal on an individual basis aiming at optimal graft survival but also at avoiding unnecessary adverse effects.
authors.affiliation: Hospital for Children and Adolescents, Helsinki University Central Hospital, Finland.
authors.forename: J
authors.initials: J
authors.lastname: Laine
authors.forename: H
authors.initials: H
authors.lastname: Jalanko
authors.forename: K
authors.initials: K
authors.lastname: Rönnholm
authors.forename: H
authors.initials: H
authors.lastname: Sairanen
authors.forename: K
authors.initials: K
authors.lastname: Salmela
authors.forename: M
authors.initials: M
authors.lastname: Leijala
authors.forename: C
authors.initials: C
authors.lastname: Holmberg
mesh_terms: D000293:Adolescent; D000328:Adult; D002648:Child; D002675:Child, Preschool; D006084:Graft Rejection; D006085:Graft Survival; D006130:Growth Disorders / Q000188:drug therapy / Q000209:etiology; D019382:Human Growth Hormone / Q000627:therapeutic use; D006801:Humans; D007165:Immunosuppression Therapy; D007166:Immunosuppressive Agents / Q000009:adverse effects / Q000627:therapeutic use; D007223:Infant; D007676:Kidney Failure, Chronic / Q000453:epidemiology / Q000601:surgery*; D016030:Kidney Transplantation; D010349:Patient Compliance; D012008:Recurrence
chemical_list: D007166:Immunosuppressive Agents; D019382:Human Growth Hormone